Advertisement

Parasitology Research

, Volume 96, Issue 4, pp 273–275 | Cite as

Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole

  • Davood. Dorostkar MoghaddamEmail author
  • E. Ghadirian
  • M. Azami
Original Paper

Abstract

Blastocystis hominis is commonly found in the intestinal tract of humans. Although the pathogenicity of this unicellular parasite is controversial, anti-protozoan agents are usually administered to infected individuals. At present, the first choice of chemotherapeutic agent is Metronidazole as described in the literature. In this study, we evaluated the effects of metronidazole and Trimethoprim/Sulfamethoxazole (TMP/SMX) on persons infected with B.hominis. A total of 104 subjects infected with B. hominis were admitted to the laboratory from 2002 to 2003. All individuals were non-immunocompromised and subjects were monitored for 1 year after treatment. All stool samples were microscopically examined after staining with iodine and by culturing in an egg slant medium. Of the 104 infected individuals (52±16 years of age, M:F=60:44) with B. hominis infection, 28 were discharging large numbers of parasites before treatment. Of 28 severely infected individuals, 12 were treated with metronidazole/250–750 mg at a regimen of 3x/day/10 days and 4 of the 12 were eradicated. Nine individuals were treated with TMP/SMX/1tab at a regimen of 3x/day/10 days and 2 of the 9 were eradicated. For severe B. hominis infections, it appears that metronidazole and TMP/SMX are effective in some individuals, but not all.

Keywords

Irritable Bowel Syndrome Metronidazole Infected Individual Stool Sample Pentamidine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Alexeieff A (1911) Sur la nature des formations dites kystes de Trichomonas intestinalis. C R Soc Biol 71:296–298Google Scholar
  2. Zierdt CH, Rude WS, Bull BS (1967) Protozoan characteristics of Blastocystis hominis. Am J Clin Pathol 48:495–501PubMedGoogle Scholar
  3. Editorial (1991) Blastocystis hominis: commensal or pathogen? Lancet 337:521–522Google Scholar
  4. Wolfe MS (1982) The treatment of intestinal protozoan infections. Med Clin North Am 66:707–720PubMedGoogle Scholar
  5. Zierdt CH, Swan JC, Hosseini J (1983) In vitro response of Blastocystis hominis to antiprotozoal drugs. J Protozool 30:332–334PubMedGoogle Scholar
  6. Dunn LA and Boreham PF (1991) The in-vitro activity of drugs against Blastocystis hominis. J Antimicrob Chemother 27:507–516PubMedGoogle Scholar
  7. Thathaisong U, Worapong J, Mungthin M, Tan-Ariya P, Viputtigul K, Sudatis A, Noonai A, Leelayoova S (2003) Blastocystis Isolates from a Pig and a Horse Are Closely Related to Blastocystis hominis. J Clin Microbiol 41:967–975Google Scholar
  8. Taamasri P, Leelayoova S, Rangsin R, Naaglor T, Ketupanya A, Mungthin M (2002) Prevalence of Blastocystis hominis carriage in Thaiarmy personnel based in Chonburi. Thai Mil Med 167:643–646Google Scholar
  9. Udkow MP, Markell EK (1993) Blastocystis hominis: prevalence in asymptomatic versus symptomatic hosts. J Infect Dis 168:242–244PubMedGoogle Scholar
  10. Sohail MR, Fischer PR (2004) Blastocystis hominis and travelers. Travel Med Infect Dis Article (in press)Google Scholar
  11. Stenzel DJ, Boreham PFL (1996) Blastocystis hominis revisited. Clin Microbiol Rev 9:563–584Google Scholar
  12. Cirioni O, Giacometti A, Drenaggi D, Ancarani F, Scalise G (1999) Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol 15:989–993CrossRefGoogle Scholar
  13. Church DL, Sutheland L, Gill MJ, Visser ND, Kelly JK, Bryant H, Hwang W, Sharkey K (1992) Absence of an association between enteric parasites in the manifestations and pathogenesis of HIV enteropathy in gay men. Scand J Infect Dis 24:567–575PubMedGoogle Scholar
  14. Carrascosa M, Martinez J, Perez-Castrillon JL (1996) Hemorrhagic proctosigmoiditis and Blastocystis hominis infection. Ann Intern Med 124: 278–279Google Scholar
  15. O‘Gorman MA, Orenstein SR, Proujansky R, Wadowsky RM, Putnam PE, Kocoshis SA (1993) Prevalence and characteristics of Blastocystis hominis infection in children. Clin Pediatr (Phila) 32:91–96Google Scholar
  16. Hazen KC (1993) Controversial fungal and protozoab gastrointestinal infections. Curr Opin Infect Dis 6:77–82Google Scholar
  17. Lee MJ (1991) Pathogenicity of Blastocystis hominis (Letter). J Clin Microbiol 29:2089Google Scholar
  18. Markell EK, Udkow MP (1990) Association of Blastocystis hominis with human disease? (Letter) J Clin Microbiol 28:1085PubMedGoogle Scholar
  19. Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, Cacopardo B (2003) A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 10:128–130PubMedGoogle Scholar
  20. Haresh K, Suresh K, Khairul Anus A, Saminathan S (1999) Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 4:274–277CrossRefPubMedGoogle Scholar
  21. Zaman V, Zaki M (1996) Resistance of Blastocystis hominis cysts to metronidazole. Trop Med Int Health 1:677–678PubMedGoogle Scholar
  22. Garavelli PL, Scaglione L, Bicocchi R, Libanore M (1991) Pathogenicity of Blastocystis hominis (Letter). Infection 19:185CrossRefPubMedGoogle Scholar
  23. Garavelli PL, Libanore M (1990) Blastocystis immunodeficiency disease (Letter). Rev Infect Dis 12:158PubMedGoogle Scholar
  24. Telalbasic S, Pikula ZP, Kapidzic M (1991) Blastocystis Hominis may be a potential cause of intestinal disease. Scand J Infect Dis 23:389–390PubMedGoogle Scholar
  25. Hahn P, Fleischer NFK (1985) Blastocystis hominis-is it of clinical importance? Trop Med Parasitol 36:7–8PubMedGoogle Scholar
  26. Ok UZ, Girginkardesler N, Balcioglu C, Ertan P, Pirildar T, Kilimcioglu AA (1999) Effect of trimethoprim–sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 94:3245–3247CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Davood. Dorostkar Moghaddam
    • 1
    Email author
  • E. Ghadirian
    • 2
  • M. Azami
    • 1
  1. 1.Department of Parasitology and Mycology, School of MedicineIsfahan University of Medical SciencesIsfahanIran
  2. 2.Shahid Mohammad Montazeri HospitalIsfahan University of Medical SciencesIsfahanIran

Personalised recommendations